Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhaoxiang Xie

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Nanotheranostics|May 31, 2021
Pentraxin 3: a powerful orchestrator in urinary tract infectionCheng Qiu, Tianyi Liu, Dan Luo, et al.
Cancer Pathogenesis and Therapy|February 8, 2024
Inaugurating a novel adjuvant therapy in urological cancers: FerroptosisZhaoxiang Xie, Qianghua Zhou, Cheng Qiu, et al.
Inflammation|September 13, 2020
ROS-Dependent Lipid Peroxidation and Reliant Antioxidant Ferroptosis-Suppressor-Protein 1 in Rheumatoid Arthritis: a Covert Clue for Potential TherapyZhaoxiang Xie, Haodong Hou, Dan Luo, et al.
Current Problems in Surgery|June 13, 2026
Postoperative urinary retention in patients undergoing elective spine surgeryZhiyuan Xiao, Shiyuan Han, Zhaoxiang Xie, et al.
Biomaterials Science|July 14, 2022
Delivery of enzalutamide <i>via</i> nanoparticles for effectively inhibiting prostate cancer progressionZe Gao, Jun Huang, Zhaoxiang Xie, et al.
ACS Biomaterials Science & Engineering|June 8, 2024
Sorafenib Encapsulated Poly(ester amide) Nanoparticles for Efficient and Biosafe Prostate Cancer TherapyShunli Yu, Ruhe Zhang, Zhaoxiang Xie, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|February 16, 2023
Improved in situ sequencing for high-resolution targeted spatial transcriptomic analysis in tissue sectionsXinbin Tang, Jiayu Chen, Xinya Zhang, et al.
Materials Today. Bio|January 5, 2026
Daidzein-engineered high-accumulation self-therapeutic nanoplatform drives androgen receptor degradation via ubiquitination-proteasome system to overcome enzalutamide resistance in castration-resistant prostate cancerZhaoxiang Xie, Chunlei Dai, Zhi Xiong, et al.
Biomaterials Science|January 3, 2024
Delivery of gefitinib loaded nanoparticles for effectively inhibiting prostate cancer progressionZhi Xiong, Tong Tong, Zhaoxiang Xie, et al.
Cell Death & Disease|February 23, 2026
PDHA1-acetylation signaling suppresses cuproptosis to attenuate anti-androgen effect in prostate cancerRuilin Zhuang, Qianghua Zhou, Bisheng Cheng, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Nanotheranostics|May 31, 2021
Pentraxin 3: a powerful orchestrator in urinary tract infectionCheng Qiu, Tianyi Liu, Dan Luo, et al.
Cancer Pathogenesis and Therapy|February 8, 2024
Inaugurating a novel adjuvant therapy in urological cancers: FerroptosisZhaoxiang Xie, Qianghua Zhou, Cheng Qiu, et al.
Inflammation|September 13, 2020
ROS-Dependent Lipid Peroxidation and Reliant Antioxidant Ferroptosis-Suppressor-Protein 1 in Rheumatoid Arthritis: a Covert Clue for Potential TherapyZhaoxiang Xie, Haodong Hou, Dan Luo, et al.
Current Problems in Surgery|June 13, 2026
Postoperative urinary retention in patients undergoing elective spine surgeryZhiyuan Xiao, Shiyuan Han, Zhaoxiang Xie, et al.
Biomaterials Science|July 14, 2022
Delivery of enzalutamide <i>via</i> nanoparticles for effectively inhibiting prostate cancer progressionZe Gao, Jun Huang, Zhaoxiang Xie, et al.
ACS Biomaterials Science & Engineering|June 8, 2024
Sorafenib Encapsulated Poly(ester amide) Nanoparticles for Efficient and Biosafe Prostate Cancer TherapyShunli Yu, Ruhe Zhang, Zhaoxiang Xie, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|February 16, 2023
Improved in situ sequencing for high-resolution targeted spatial transcriptomic analysis in tissue sectionsXinbin Tang, Jiayu Chen, Xinya Zhang, et al.
Materials Today. Bio|January 5, 2026
Daidzein-engineered high-accumulation self-therapeutic nanoplatform drives androgen receptor degradation via ubiquitination-proteasome system to overcome enzalutamide resistance in castration-resistant prostate cancerZhaoxiang Xie, Chunlei Dai, Zhi Xiong, et al.
Biomaterials Science|January 3, 2024
Delivery of gefitinib loaded nanoparticles for effectively inhibiting prostate cancer progressionZhi Xiong, Tong Tong, Zhaoxiang Xie, et al.
Cell Death & Disease|February 23, 2026
PDHA1-acetylation signaling suppresses cuproptosis to attenuate anti-androgen effect in prostate cancerRuilin Zhuang, Qianghua Zhou, Bisheng Cheng, et al.
Pageof 2